Protein tyrosine phosphatase conjugated with a transdermal delivery peptide, AP-rPTP and a therapeutic agent for inflammatory skin diseases, containing same as an active ingredient

Item Number: 640
Industry: Therapeutic
Category: Dermatology
Development Stage: Early Stage
Organisation Type: University
Country: South Korea
Patent: Korea, PCT
Business Opportunity: Out-Licensing, Technology Transfer, Collaboration R&D


The present invention relates to protein tyrosine phosphatase conjugated with a novel transdermal delivery peptide, astrotactin 1–derived peptide recombinant protein tyrosine phosphatase (AP-rPTP). More particularly, it includes its use for treating inflammatory skin diseases using the above fusion peptide.

Features & Contact

Sign in and you'll be able to send enquiries about this item, view full details and save it